☰

Peter Klivenyi, MD PhD - Publications

Affiliations: 
Neurology University of Pécs, Hungary, Pécs, Hungary 
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

78/214 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Zádori D, Szalárdy L, Reisz Z, Kovacs GG, Maszlag-Török R, Ajeawung NF, Vécsei L, Campeau PM, Klivényi P. Clinicopathological Relationships in an Aged Case of DOORS Syndrome With a p.Arg506X Mutation in the Gene. Frontiers in Neurology. 11: 767. PMID 32849222 DOI: 10.3389/Fneur.2020.00767  0.305
2020 Salamon A, Zádori D, Szpisjak L, Klivényi P, Vécsei L. Fixed-dose combination therapy for Parkinson's disease with a spotlight on entacapone in the past 20 years: a reduced pill burden and a simplified dosing regime. Expert Opinion On Pharmacotherapy. 1-14. PMID 32808807 DOI: 10.1080/14656566.2020.1806237  0.422
2020 Takáts A, Aschermann Z, Vécsei L, Klivényi P, Dézsi L, Zádori D, Valikovics A, Varannai L, Onuk K, Kinczel B, Kovács N. [Advanced Parkinson's disease characteristics in clinical practice: Results from the OBSERVE-PD study and sub-analysis of the Hungarian data]. Ideggyogyaszati Szemle. 73: 261-268. PMID 32750243 DOI: 10.18071/Isz.73.0261  0.374
2020 Nánási N, Veres G, Cseh EK, Martos D, Hadady L, Klivényi P, Vécsei L, Zádori D. The assessment of possible gender-related effect of endogenous striatal alpha-tocopherol level on MPTP neurotoxicity in mice. Heliyon. 6: e04425. PMID 32685739 DOI: 10.1016/J.Heliyon.2020.E04425  0.412
2020 Salamon A, Maszlag-Török R, Veres G, Boros FA, Vágvölgyi-Sümegi E, Somogyi A, Vécsei L, Klivényi P, Zádori D. Cerebellar Predominant Increase in mRNA Expression Levels of Sirt1 and Sirt3 Isoforms in a Transgenic Mouse Model of Huntington's Disease. Neurochemical Research. PMID 32524313 DOI: 10.1007/S11064-020-03069-0  0.387
2020 Boros FA, Maszlag-Török R, Vécsei L, Klivényi P. Increased level of NEAT1 long non-coding RNA is detectable in peripheral blood cells of patients with Parkinson's disease. Brain Research. 1730: 146672. PMID 31953211 DOI: 10.1016/J.Brainres.2020.146672  0.346
2019 Salamon A, Zádori D, Szpisjak L, Klivényi P, Vécsei L. Neuroprotection in Parkinson's disease: facts and hopes. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 31828513 DOI: 10.1007/S00702-019-02115-8  0.393
2019 Illés A, Csabán D, Grosz Z, Balicza P, Gézsi A, Molnár V, Bencsik R, Gál A, Klivényi P, Molnar MJ. The Role of Genetic Testing in the Clinical Practice and Research of Early-Onset Parkinsonian Disorders in a Hungarian Cohort: Increasing Challenge in Genetic Counselling, Improving Chances in Stratification for Clinical Trials. Frontiers in Genetics. 10: 1061. PMID 31737044 DOI: 10.3389/Fgene.2019.01061  0.32
2019 Salamon A, Zádori D, Szpisjak L, Klivényi P, Vécsei L. Opicapone for the treatment of Parkinson's disease: an update. Expert Opinion On Pharmacotherapy. 1-7. PMID 31670988 DOI: 10.1080/14656566.2019.1681971  0.338
2019 Boros FA, Török R, Vágvölgyi-Sümegi E, Pesei ZG, Klivényi P, Vécsei L. Assessment of risk factor variants of LRRK2, MAPT, SNCA and TCEANC2 genes in Hungarian sporadic Parkinson's disease patients. Neuroscience Letters. 706: 140-145. PMID 31085292 DOI: 10.1016/J.Neulet.2019.05.014  0.367
2019 Szpisjak L, Zadori D, Klivenyi P, Vecsei L. Clinical characteristics and possible drug targets in autosomal dominant spinocerebellar ataxias. Cns & Neurological Disorders Drug Targets. PMID 30864514 DOI: 10.2174/1871527318666190311155846  0.313
2019 Salamon A, Torok R, Sumegi E, Boros F, Pesei ZG, Fort Molnar M, Veres G, Zadori D, Vecsei L, Klivenyi P. The effect of physical stimuli on the expression level of key elements in mitochondrial biogenesis. Neuroscience Letters. 698: 13-18. PMID 30611892 DOI: 10.1016/J.Neulet.2019.01.003  0.316
2018 Klivényi P, Vécsei L. [The treatment of advanced Parkinson's disease]. Ideggyogyaszati Szemle. 71: 377-383. PMID 30604936 DOI: 10.18071/Isz.71.0377  0.323
2018 Boros FA, Klivényi P, Toldi J, Vécsei L. Indoleamine 2,3-dioxygenase as a novel therapeutic target for Huntington's disease. Expert Opinion On Therapeutic Targets. 1-13. PMID 30449219 DOI: 10.1080/14728222.2019.1549231  0.351
2018 Szalardy L, Molnar MF, Zadori D, Cseh EK, Veres G, Kovacs GG, Vecsei L, Klivenyi P. Non-motor Behavioral Alterations of PGC-1α-Deficient Mice - A Peculiar Phenotype With Slight Male Preponderance and No Apparent Progression. Frontiers in Behavioral Neuroscience. 12: 180. PMID 30210314 DOI: 10.3389/Fnbeh.2018.00180  0.315
2018 Zádori D, Veres G, Szalárdy L, Klivényi P, Vécsei L. Alzheimer's Disease: Recent Concepts on the Relation of Mitochondrial Disturbances, Excitotoxicity, Neuroinflammation, and Kynurenines. Journal of Alzheimer's Disease : Jad. 62: 523-547. PMID 29480191 DOI: 10.3233/Jad-170929  0.344
2017 Tripolszki K, Török D, Goudenège D, Farkas K, Sulák A, Török N, Engelhardt JI, Klivényi P, Procaccio V, Nagy N, Széll M. High-throughput sequencing revealed a novel SETX mutation in a Hungarian patient with amyotrophic lateral sclerosis. Brain and Behavior. 7: e00669. PMID 28413711 DOI: 10.1002/Brb3.669  0.312
2017 Juhász A, Aschermann Z, Ács P, Janszky J, Kovács M, Makkos A, Harmat M, Tényi D, Karádi K, Komoly S, Takáts A, Tóth A, Nagy H, Klivényi P, Dibó G, et al. Levodopa/carbidopa intestinal gel can improve both motor and non-motor experiences of daily living in Parkinson's disease: An open-label study. Parkinsonism & Related Disorders. PMID 28185758 DOI: 10.1016/J.Parkreldis.2017.02.001  0.353
2017 Torok R, Salamon A, Sumegi E, Zadori D, Veres G, Molnar MF, Vecsei L, Klivenyi P. Effect of MPTP on mRNA expression of PGC-1α in mouse brain. Brain Research. PMID 28161458 DOI: 10.1016/J.Brainres.2017.01.032  0.305
2016 Aschermann Z, Dibó G, Klivényi P, Kovács N, Kovács T, Takáts A, Tamás G, Varannai L. [Recommendation for treatment options in advanced Parkinson's disease]. Ideggyogyaszati Szemle. 69: 367-372. PMID 29733553 DOI: 10.18071/Isz.69.0367  0.337
2016 Molnár MF, Török R, Szalárdy L, Sümegi E, Vécsei L, Klivényi P. High-dose 1,25-dihydroxyvitamin D supplementation elongates the lifespan of Huntington's disease transgenic mice. Acta Neurobiologiae Experimentalis. 76: 176-81. PMID 27685770 DOI: 10.21307/Ane-2017-017  0.371
2016 Tamás G, Kelemen A, Radics P, Valálik I, Heldman D, Klivényi P, Vécsei L, Hidasi E, Halász L, Kis D, Barsi P, Golopencza P, Erőss L. Effect of subthalamic stimulation on distal and proximal upper limb movements in Parkinson's disease. Brain Research. PMID 27543337 DOI: 10.1016/J.Brainres.2016.08.019  0.311
2016 Ács P, Molnár MJ, Klivényi P, Kálmán B. [GENETICALLY DETERMINED DISEASES ASSOCIATED WITH PATHOLOGICAL BRAIN IRON ACCUMULATION AND NEURODEGENERATION]. IdeggyóGyáSzati Szemle. 69: 157-66. PMID 27468605 DOI: 10.18071/Isz.69.0157  0.306
2016 Szalardy L, Molnar M, Torok R, Zadori D, Kovacs GG, Vecsei L, Klivenyi P. Lack of age-related clinical progression in PGC-1α-deficient mice - implications for mitochondrial encephalopathies. Behavioural Brain Research. PMID 27424777 DOI: 10.1016/J.Bbr.2016.07.021  0.401
2016 Szalardy L, Molnar M, Torok R, Zadori D, Vecsei L, Klivenyi P, Liberski P, Kovacs GG. Histopathological comparison of Kearns-Sayre syndrome and PGC-1α-deficient mice suggests a novel concept for vacuole formation in mitochondrial encephalopathy. Folia Neuropathologica / Association of Polish Neuropathologists and Medical Research Centre, Polish Academy of Sciences. 54: 9-22. PMID 27179217 DOI: 10.5114/Fn.2016.58911  0.354
2016 Zádori D, Veres G, Szalárdy L, Klivényi P, Fülöp F, Toldi J, Vécsei L. Inhibitors of the kynurenine pathway as neurotherapeutics: a patent review (2012-2015). Expert Opinion On Therapeutic Patents. PMID 27172114 DOI: 10.1080/13543776.2016.1189531  0.305
2015 Török R, Zádori D, Török N, Csility É, Vécsei L, Klivényi P. An assessment of the frequency of mutations in the GBA and VPS35 genes in Hungarian patients with sporadic Parkinson's disease. Neuroscience Letters. PMID 26547032 DOI: 10.1016/J.Neulet.2015.11.001  0.305
2015 Szalárdy L, Zádori D, Klivényi P, Toldi J, Vécsei L. Electron Transport Disturbances and Neurodegeneration: From Albert Szent-Györgyi's Concept (Szeged) till Novel Approaches to Boost Mitochondrial Bioenergetics. Oxidative Medicine and Cellular Longevity. 2015: 498401. PMID 26301042 DOI: 10.1155/2015/498401  0.395
2015 Török N, Török R, Szolnoki Z, Somogyvári F, Klivényi P, Vécsei L. The Genetic Link between Parkinson's Disease and the Kynurenine Pathway Is Still Missing. Parkinson's Disease. 2015: 474135. PMID 25785227 DOI: 10.1155/2015/474135  0.34
2015 Veres G, Molnár M, Zádori D, Szentirmai M, Szalárdy L, Török R, Fazekas E, Ilisz I, Vécsei L, Klivényi P. Central nervous system-specific alterations in the tryptophan metabolism in the 3-nitropropionic acid model of Huntington's disease. Pharmacology, Biochemistry, and Behavior. 132: 115-124. PMID 25773340 DOI: 10.1016/J.Pbb.2015.03.002  0.411
2015 Török R, Kónya JA, Zádori D, Veres G, Szalárdy L, Vécsei L, Klivényi P. mRNA expression levels of PGC-1α in a transgenic and a toxin model of Huntington's disease. Cellular and Molecular Neurobiology. 35: 293-301. PMID 25319408 DOI: 10.1007/S10571-014-0124-Z  0.322
2014 Zádori D, Veres G, Szalárdy L, Klivényi P, Toldi J, Vécsei L. Glutamatergic dysfunctioning in Alzheimer's disease and related therapeutic targets. Journal of Alzheimer's Disease : Jad. 42: S177-87. PMID 24670398 DOI: 10.3233/Jad-132621  0.32
2013 Török R, Török N, Szalardy L, Plangar I, Szolnoki Z, Somogyvari F, Vecsei L, Klivenyi P. Association of vitamin D receptor gene polymorphisms and Parkinson's disease in Hungarians. Neuroscience Letters. 551: 70-4. PMID 23880018 DOI: 10.1016/J.Neulet.2013.07.014  0.304
2013 Szalardy L, Zadori D, Plangar I, Vecsei L, Weydt P, Ludolph AC, Klivenyi P, Kovacs GG. Neuropathology of partial PGC-1α deficiency recapitulates features of mitochondrial encephalopathies but not of neurodegenerative diseases. Neuro-Degenerative Diseases. 12: 177-88. PMID 23406886 DOI: 10.1159/000346267  0.395
2013 Molnar M, Szalardy L, Zadori D, Vecsei L, Klivenyi P. Revisiting the observation of anxiety-like behavior and assessing phenotypic progression in PGC-1α-deficient mice Journal of the Neurological Sciences. 333: e727. DOI: 10.1016/J.Jns.2013.07.2508  0.316
2012 Szalardy L, Zadori D, Toldi J, Fulop F, Klivenyi P, Vecsei L. Manipulating kynurenic acid levels in the brain - on the edge between neuroprotection and cognitive dysfunction. Current Topics in Medicinal Chemistry. 12: 1797-806. PMID 23030614 DOI: 10.2174/156802612803989264  0.308
2012 Nemeth D, Dye CD, Sefcsik T, Janacsek K, Turi Z, Londe Z, Klivenyi P, Kincses ZT, Szabó N, Vecsei L, Ullman MT. Language deficits in pre-symptomatic Huntington's disease: evidence from Hungarian. Brain and Language. 121: 248-53. PMID 22538085 DOI: 10.1016/J.Bandl.2012.04.001  0.315
2012 Szalardy L, Klivenyi P, Zadori D, Fulop F, Toldi J, Vecsei L. Mitochondrial disturbances, tryptophan metabolites and neurodegeneration: medicinal chemistry aspects. Current Medicinal Chemistry. 19: 1899-920. PMID 22429096 DOI: 10.2174/092986712800167365  0.372
2011 Klivenyi P, Vecsei L. Pharmacological models of Parkinson's disease in rodents. Methods in Molecular Biology (Clifton, N.J.). 793: 211-27. PMID 21913103 DOI: 10.1007/978-1-61779-328-8_14  0.41
2010 Spitzer P, Klafki HW, Blennow K, Buée L, Esselmann H, Herruka SK, Jimenez C, Klivenyi P, Lewczuk P, Maler JM, Markus K, Meyer HE, Morris C, Müller T, Otto M, et al. cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases. International Journal of Alzheimer's Disease. 2010. PMID 20886057 DOI: 10.4061/2010/548145  0.308
2010 Vamos E, Voros K, Vecsei L, Klivenyi P. Neuroprotective effects of L-carnitine in a transgenic animal model of Huntington's disease. Biomedicine & Pharmacotherapy = Biomã©Decine & Pharmacothã©Rapie. 64: 282-6. PMID 19932584 DOI: 10.1016/J.Biopha.2009.06.020  0.411
2010 Klivenyi P, Vecsei L. Novel therapeutic strategies in Parkinson's disease. European Journal of Clinical Pharmacology. 66: 119-25. PMID 19834698 DOI: 10.1007/S00228-009-0742-4  0.362
2009 Vamos E, Voros K, Zadori D, Vecsei L, Klivenyi P. Neuroprotective effects of probenecid in a transgenic animal model of Huntington's disease. Journal of Neural Transmission (Vienna, Austria : 1996). 116: 1079-86. PMID 19551467 DOI: 10.1007/S00702-009-0253-6  0.451
2009 Vamos E, Csati A, Vecsei L, Klivenyi P. Effects of valproate on the dopaminergic system in mice. Neurological Research. 31: 217-9. PMID 18768113 DOI: 10.1179/174313208X346099  0.4
2007 Hartai Z, Klivenyi P, Janaky T, Penke B, Dux L, Vecsei L. Peripheral kynurenine metabolism in focal dystonia. Medicinal Chemistry (ShäRiqah (United Arab Emirates)). 3: 285-8. PMID 17504201 DOI: 10.2174/157340607780620707  0.336
2007 Vamos E, Csati A, Klivenyi P, Vecsei L. 1.319 Effects of valproate on dopaminergic system in mice Parkinsonism & Related Disorders. 13. DOI: 10.1016/S1353-8020(08)70554-6  0.408
2006 Klivenyi P, Bende Z, Hartai Z, Penke Z, Nemeth H, Toldi J, Vecsei L. Behaviour changes in a transgenic model of Huntington's disease. Behavioural Brain Research. 169: 137-41. PMID 16443291 DOI: 10.1016/J.Bbr.2006.01.003  0.423
2006 Klivenyi P, Siwek D, Gardian G, Yang L, Starkov A, Cleren C, Ferrante RJ, Kowall NW, Abeliovich A, Beal MF. Mice lacking alpha-synuclein are resistant to mitochondrial toxins. Neurobiology of Disease. 21: 541-8. PMID 16298531 DOI: 10.1016/J.Nbd.2005.08.018  0.787
2005 Klivenyi P, Kekesi KA, Hartai Z, Juhasz G, Vecsei L. Effects of mitochondrial toxins on the brain amino acid concentrations. Neurochemical Research. 30: 1421-7. PMID 16341939 DOI: 10.1007/S11064-005-8512-X  0.367
2005 Hartai Z, Klivenyi P, Janaky T, Penke B, Dux L, Vecsei L. Kynurenine metabolism in plasma and in red blood cells in Parkinson's disease. Journal of the Neurological Sciences. 239: 31-5. PMID 16099471 DOI: 10.1016/J.Jns.2005.07.006  0.339
2005 Hartai Z, Klivenyi P, Janaky T, Penke B, Dux L, Vecsei L. Kynurenine metabolism in multiple sclerosis. Acta Neurologica Scandinavica. 112: 93-6. PMID 16008534 DOI: 10.1111/J.1600-0404.2005.00442.X  0.305
2005 Gardian G, Browne SE, Choi DK, Klivenyi P, Gregorio J, Kubilus JK, Ryu H, Langley B, Ratan RR, Ferrante RJ, Beal MF. Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease. The Journal of Biological Chemistry. 280: 556-63. PMID 15494404 DOI: 10.1074/Jbc.M410210200  0.792
2004 Klivenyi P, Gardian G, Calingasan NY, Yang L, von Borstel R, Saydoff J, Browne SE, Beal MF. Neuroprotective effects of oral administration of triacetyluridine against MPTP neurotoxicity. Neuromolecular Medicine. 6: 87-92. PMID 15970626 DOI: 10.1385/Nmm:6:2-3:087  0.796
2004 Gardian G, Yang L, Cleren C, Calingasan NY, Klivenyi P, Beal MF. Neuroprotective effects of phenylbutyrate against MPTP neurotoxicity. Neuromolecular Medicine. 5: 235-41. PMID 15626823 DOI: 10.1385/Nmm:5:3:235  0.799
2004 Klivenyi P, Calingasan NY, Starkov A, Stavrovskaya IG, Kristal BS, Yang L, Wieringa B, Beal MF. Neuroprotective mechanisms of creatine occur in the absence of mitochondrial creatine kinase. Neurobiology of Disease. 15: 610-7. PMID 15056469 DOI: 10.1016/J.Nbd.2003.12.014  0.722
2004 Klivenyi P, Starkov AA, Calingasan NY, Gardian G, Browne SE, Yang L, Bubber P, Gibson GE, Patel MS, Beal MF. Mice deficient in dihydrolipoamide dehydrogenase show increased vulnerability to MPTP, malonate and 3-nitropropionic acid neurotoxicity. Journal of Neurochemistry. 88: 1352-60. PMID 15009635 DOI: 10.1046/J.1471-4159.2003.02263.X  0.804
2004 Klivenyi P, Kiaei M, Gardian G, Calingasan NY, Beal MF. Additive neuroprotective effects of creatine and cyclooxygenase 2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis. Journal of Neurochemistry. 88: 576-82. PMID 14720207 DOI: 10.1046/J.1471-4159.2003.02160.X  0.789
2003 Klivenyi P, Gardian G, Calingasan NY, Yang L, Beal MF. Additive neuroprotective effects of creatine and a cyclooxygenase 2 inhibitor against dopamine depletion in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease. Journal of Molecular Neuroscience : Mn. 21: 191-8. PMID 14645986 DOI: 10.1385/Jmn:21:3:191  0.798
2003 Barberi T, Klivenyi P, Calingasan NY, Lee H, Kawamata H, Loonam K, Perrier AL, Bruses J, Rubio ME, Topf N, Tabar V, Harrison NL, Beal MF, Moore MA, Studer L. Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice. Nature Biotechnology. 21: 1200-7. PMID 14502203 DOI: 10.1038/Nbt870  0.505
2003 Klivenyi P, Ferrante RJ, Gardian G, Browne S, Chabrier PE, Beal MF. Increased survival and neuroprotective effects of BN82451 in a transgenic mouse model of Huntington's disease. Journal of Neurochemistry. 86: 267-72. PMID 12807446 DOI: 10.1046/J.1471-4159.2003.T01-1-01868.X  0.8
2003 Klivenyi P, Ferrante RJ, Gardian G, Browne S, Chabrier PE, Beal MF. Erratum: Increased survival and neuroprotective effects of BN82451 in a transgenic mouse model of Huntington's disease (Journal of Neurochemistry (2003) 86 (267-272)) Journal of Neurochemistry. 87. DOI: 10.1046/J.1471-4159.2003.01868.X  0.79
2001 Andreassen OA, Ferrante RJ, Klivenyi P, Klein AM, Dedeoglu A, Albers DS, Kowall NW, Beal MF. Transgenic ALS mice show increased vulnerability to the mitochondrial toxins MPTP and 3-nitropropionic acid. Experimental Neurology. 168: 356-63. PMID 11259123 DOI: 10.1006/Exnr.2001.7627  0.649
2001 Klivenyi P, Karg E, Rozsa C, Horvath R, Komoly S, Nemeth I, Turi S, Vecsei L. alpha-Tocopherol/lipid ratio in blood is decreased in patients with Leber's hereditary optic neuropathy and asymptomatic carriers of the 11778 mtDNA mutation. Journal of Neurology, Neurosurgery, and Psychiatry. 70: 359-62. PMID 11181859 DOI: 10.1136/Jnnp.70.3.359  0.316
2001 Andreassen OA, Ferrante RJ, Dedeoglu A, Albers DW, Klivenyi P, Carlson EJ, Epstein CJ, Beal MF. Mice with a partial deficiency of manganese superoxide dismutase show increased vulnerability to the mitochondrial toxins malonate, 3-nitropropionic acid, and MPTP. Experimental Neurology. 167: 189-95. PMID 11161607 DOI: 10.1006/Exnr.2000.7525  0.664
2000 Andreassen OA, Dedeoglu A, Klivenyi P, Beal MF, Bush AI. N-acetyl-L-cysteine improves survival and preserves motor performance in an animal model of familial amyotrophic lateral sclerosis. Neuroreport. 11: 2491-3. PMID 10943709 DOI: 10.1097/00001756-200008030-00029  0.61
2000 Andreassen OA, Ferrante RJ, Hughes DB, Klivenyi P, Dedeoglu A, Ona VO, Friedlander RM, Beal MF. Malonate and 3-nitropropionic acid neurotoxicity are reduced in transgenic mice expressing a caspase-1 dominant-negative mutant. Journal of Neurochemistry. 75: 847-52. PMID 10899963 DOI: 10.1046/J.1471-4159.2000.0750847.X  0.623
2000 Klivenyi P, Andreassen OA, Ferrante RJ, Lancelot E, Reif D, Beal MF. Inhibition of neuronal nitric oxide synthase protects against MPTP toxicity. Neuroreport. 11: 1265-8. PMID 10817604 DOI: 10.1097/00001756-200004270-00024  0.763
2000 Jenkins BG, Klivenyi P, Kustermann E, Andreassen OA, Ferrante RJ, Rosen BR, Beal MF. Nonlinear decrease over time in N-acetyl aspartate levels in the absence of neuronal loss and increases in glutamine and glucose in transgenic Huntington's disease mice. Journal of Neurochemistry. 74: 2108-19. PMID 10800956 DOI: 10.1046/J.1471-4159.2000.0742108.X  0.617
2000 Andreassen OA, Ferrante RJ, Klivenyi P, Klein AM, Shinobu LA, Epstein CJ, Beal MF. Partial deficiency of manganese superoxide dismutase exacerbates a transgenic mouse model of amyotrophic lateral sclerosis. Annals of Neurology. 47: 447-55. PMID 10762155 DOI: 10.1002/1531-8249(200004)47:4<447::Aid-Ana7>3.0.Co;2-R  0.78
2000 Klivenyi P, Andreassen OA, Ferrante RJ, Dedeoglu A, Mueller G, Lancelot E, Bogdanov M, Andersen JK, Jiang D, Beal MF. Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 1-7. PMID 10627575 DOI: 10.1523/Jneurosci.20-01-00001.2000  0.782
1999 Matthews RT, Ferrante RJ, Klivenyi P, Yang L, Klein AM, Mueller G, Kaddurah-Daouk R, Beal MF. Creatine and cyclocreatine attenuate MPTP neurotoxicity. Experimental Neurology. 157: 142-9. PMID 10222117 DOI: 10.1006/Exnr.1999.7049  0.77
1999 Matthews RT, Klivenyi P, Mueller G, Yang L, Wermer M, Thomas CE, Beal MF. Novel free radical spin traps protect against malonate and MPTP neurotoxicity. Experimental Neurology. 157: 120-6. PMID 10222114 DOI: 10.1006/Exnr.1999.7045  0.731
1999 Klivenyi P, Ferrante RJ, Matthews RT, Bogdanov MB, Klein AM, Andreassen OA, Mueller G, Wermer M, Kaddurah-Daouk R, Beal MF. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nature Medicine. 5: 347-50. PMID 10086395 DOI: 10.1038/6568  0.707
1998 Klivenyi P, St Clair D, Wermer M, Yen HC, Oberley T, Yang L, Flint Beal M. Manganese superoxide dismutase overexpression attenuates MPTP toxicity. Neurobiology of Disease. 5: 253-8. PMID 9848095 DOI: 10.1006/Nbdi.1998.0191  0.68
1998 Bogdanov MB, Ferrante RJ, Kuemmerle S, Klivenyi P, Beal MF. Increased vulnerability to 3-nitropropionic acid in an animal model of Huntington's disease. Journal of Neurochemistry. 71: 2642-4. PMID 9832167 DOI: 10.1046/J.1471-4159.1998.71062642.X  0.583
1998 Klivenyi P, Beal MF, Ferrante RJ, Andreassen OA, Wermer M, Chin MR, Bonventre JV. Mice deficient in group IV cytosolic phospholipase A2 are resistant to MPTP neurotoxicity. Journal of Neurochemistry. 71: 2634-7. PMID 9832165 DOI: 10.1046/J.1471-4159.1998.71062634.X  0.617
1998 Klivenyi P, Matthews RT, Wermer M, Yang L, MacGarvey U, Becker DA, Natero R, Beal MF. Azulenyl nitrone spin traps protect against MPTP neurotoxicity. Experimental Neurology. 152: 163-6. PMID 9682023 DOI: 10.1006/Exnr.1998.6824  0.675
1995 Vécsei L, Klivényi P. Somatostatin and Alzheimer's disease. Archives of Gerontology and Geriatrics. 21: 35-41. PMID 15374222 DOI: 10.1016/0167-4943(95)00640-7  0.369
Low-probability matches (unlikely to be authored by this person)
2018 Sandi D, Bereg E, Biernacki T, Vörös E, Klivényi P, Bereczki C, Vécsei L, Bencsik K. Pediatric multiple sclerosis and fulminant disease course: Features and approaches to treatment - A case report and review of the literature. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. PMID 29731272 DOI: 10.1016/J.Jocn.2018.04.053  0.295
2019 Salamon A, Zádori D, Horváth E, Vécsei L, Klivényi P. [Zonisamide treatment in myoclonus-dystonia]. Orvosi Hetilap. 160: 1353-1357. PMID 31423828 DOI: 10.1556/650.2019.31472  0.295
2019 Cseh EK, Veres G, Danics K, Szalárdy L, Nánási N, Klivényi P, Vécsei L, Zádori D. Additional value of tau protein measurement in the diagnosis of Creutzfeldt-Jakob disease. Ideggyogyaszati Szemle. 72: 39-47. PMID 30785245 DOI: 10.18071/Isz.72.0039  0.294
2017 Tripolszki K, Csányi B, Nagy D, Ratti A, Tiloca C, Silani V, Kereszty É, Török N, Vécsei L, Engelhardt JI, Klivényi P, Nagy N, Széll M. Genetic analysis of the SOD1 and C9ORF72 genes in Hungarian patients with amyotrophic lateral sclerosis. Neurobiology of Aging. PMID 28222900 DOI: 10.1016/J.Neurobiolaging.2017.01.016  0.294
2018 Márki S, Göblös A, Szlávicz E, Török N, Balicza P, Bereznai B, Takáts A, Engelhardt J, Klivényi P, Vécsei L, Molnár MJ, Nagy N, Széll M. The rs13388259 Intergenic Polymorphism in the Genomic Context of the Gene Is Associated with Parkinson's Disease in the Hungarian Population. Parkinson's Disease. 2018: 9351598. PMID 29850016 DOI: 10.1155/2018/9351598  0.294
2019 Tripolszki K, Gampawar P, Schmidt H, Nagy ZF, Nagy D, Klivényi P, Engelhardt JI, Széll M. Comprehensive Genetic Analysis of a Hungarian Amyotrophic Lateral Sclerosis Cohort. Frontiers in Genetics. 10: 732. PMID 31475037 DOI: 10.3389/Fgene.2019.00732  0.294
2014 Oláh Z, Pákáski M, Zvara A, Klivényi P, Ivitz E, Sántha M, Vécsei L, Janka Z. EPA-0381 – Preliminary studies on cerebrospinal fluid of patient with alzheimer's disease using peptide microarray European Psychiatry. 29: 1. DOI: 10.1016/S0924-9338(14)77804-6  0.292
2013 Szalardy L, Zadori D, Tanczos E, Simu M, Bencsik K, Vecsei L, Klivenyi P. Elevated levels of PPAR-gamma in the cerebrospinal fluid of patients with multiple sclerosis. Neuroscience Letters. 554: 131-4. PMID 24021801 DOI: 10.1016/J.Neulet.2013.08.069  0.291
2017 Pákáski M, Balogh G, Datki Z, Horváth I, Ivitz E, Klivényi P, Kovács T, Oláh Z, Péter M, Török Z, Várhelyi Z, Vigh L, Zádori D, Kálmán J. Cerebrospinal Fluid Lipidomic Profile In Alzheimer’S Disease Alzheimers & Dementia. 13: 708. DOI: 10.1016/J.Jalz.2017.06.902  0.289
2009 Vamos E, Pardutz A, Klivenyi P, Toldi J, Vecsei L. The role of kynurenines in disorders of the central nervous system: possibilities for neuroprotection. Journal of the Neurological Sciences. 283: 21-7. PMID 19268309 DOI: 10.1016/J.Jns.2009.02.326  0.289
2018 Nánási N, Veres G, Cseh EK, Szentirmai M, Martos D, Sümegi E, Hadady L, Klivényi P, Vécsei L, Zádori D. The detection of age-, gender-, and region-specific changes in mouse brain tocopherol levels via the application of different validated HPLC methods. Neurochemical Research. PMID 30194607 DOI: 10.1007/S11064-018-2630-8  0.289
2020 Cseh EK, Veres G, Körtési T, Polyák H, Nánási N, Tajti J, Párdutz Á, Klivényi P, Vécsei L, Zádori D. Neurotransmitter and tryptophan metabolite concentration changes in the complete Freund's adjuvant model of orofacial pain. The Journal of Headache and Pain. 21: 35. PMID 32316909 DOI: 10.1186/S10194-020-01105-6  0.284
2016 Balicza P, Grosz Z, Gonzalez MA, Bencsik R, Pentelenyi K, Gal A, Varga E, Klivenyi P, Koller J, Züchner S, Molnar JM. Genetic background of the hereditary spastic paraplegia phenotypes in Hungary - An analysis of 58 probands. Journal of the Neurological Sciences. 364: 116-21. PMID 27084228 DOI: 10.1016/J.Jns.2016.03.018  0.282
2016 Szpisjak L, Zsindely N, Engelhardt JI, Vecsei L, Kovacs GG, Klivenyi P. Novel AARS2 gene mutation producing leukodystrophy: a case report. Journal of Human Genetics. PMID 27734837 DOI: 10.1038/Jhg.2016.126  0.282
2013 Szalardy L, Zadori D, Simu M, Bencsik K, Vecsei L, Klivenyi P. Evaluating biomarkers of neuronal degeneration and neuroinflammation in CSF of patients with multiple sclerosis-osteopontin as a potential marker of clinical severity. Journal of the Neurological Sciences. 331: 38-42. PMID 23706476 DOI: 10.1016/J.Jns.2013.04.024  0.281
2017 Zádori D, Füvesi J, Timár E, Horváth E, Bencsik R, Szépfalusi N, Must A, Vécsei L, Molnár MJ, Klivényi P. The Report of p.Val717Phe Mutation in the APP Gene in a Hungarian Family With Alzheimer Disease: A Phenomenological Study. Alzheimer Disease and Associated Disorders. PMID 28796010 DOI: 10.1097/Wad.0000000000000206  0.28
2019 Salamon A, Faragó P, Németh VL, Szépfalusi N, Horváth E, Vass A, Bereczky Z, Tajti J, Vécsei L, Klivényi P, Zádori D. [Multiple ischemic stroke in Osler-Rendu-Weber disease]. Ideggyogyaszati Szemle. 72: 65-70. PMID 30785249 DOI: 10.18071/Https://Doi.Org/10.18071/Isz.72.0065  0.28
2019 Tripolszki K, Danis J, Padhi AK, Gomes J, Bozó R, Nagy ZF, Nagy D, Klivényi P, Engelhardt JI, Széll M. Angiogenin mutations in Hungarian patients with amyotrophic lateral sclerosis: Clinical, genetic, computational, and functional analyses. Brain and Behavior. e01293. PMID 31025543 DOI: 10.1002/Brb3.1293  0.28
2017 Juhász A, Aschermann Z, Ács P, Janszky JV, Kovács M, Makkos A, Tényi D, Karádi K, Komoly S, Klivényi P, Dézsi L, Zádori D, Annus Á, Vécsei L, Kovács N. Levodopa/carbidopa intestinal gel can improve both motor and non-motor experiences of daily living in Parkinson’s disease Journal of the Neurological Sciences. 381: 123-124. DOI: 10.1016/J.Jns.2017.08.380  0.279
2019 Szpisjak L, Salamon A, Zadori D, Klivenyi P, Vecsei L. Selecting dopamine depleters for hyperkinetic movement disorders: how do we choose? Expert Opinion On Pharmacotherapy. 1-4. PMID 31663787 DOI: 10.1080/14656566.2019.1685980  0.267
2016 Zádori D, Szpisjak L, Madar L, Varga VE, Csányi B, Bencsik K, Balogh I, Harangi M, Kereszty É, Vécsei L, Klivényi P. Different phenotypes in identical twins with cerebrotendinous xanthomatosis: case series. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. PMID 27888347 DOI: 10.1007/S10072-016-2776-6  0.265
2011 Mattsson N, Andreasson U, Persson S, Arai H, Batish SD, Bernardini S, Bocchio-Chiavetto L, Blankenstein MA, Carrillo MC, Chalbot S, Coart E, Chiasserini D, Cutler N, Dahlfors G, Duller S, ... ... Klivenyi P, et al. The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 7: 386-395.e6. PMID 21784349 DOI: 10.1016/J.Jalz.2011.05.2243  0.262
2016 Kovács N, Horváth K, Aschermann Z, Ács P, Bosnyák E, Deli G, Pál E, Janszky J, Faludi B, Karádi K, Késmárki I, Bokor M, Rigó E, Lajtos J, Klivényi P, et al. Independent validation of Parkinson'S disease Sleep Scale 2nd version (PDSS-2) Sleep and Biological Rhythms. 14: 63-73. DOI: 10.1007/S41105-015-0024-8  0.261
2017 Szalardy L, Zadori D, Bencsik K, Vecsei L, Klivenyi P. Unlike PPARgamma, neither other PPARs nor PGC-1alpha is elevated in the cerebrospinal fluid of patients with multiple sclerosis. Neuroscience Letters. 651: 128-133. PMID 28483651 DOI: 10.1016/J.Neulet.2017.05.008  0.26
2019 Zádori D, Szpisjak L, Németh IB, Reisz Z, Kovacs GG, Szépfalusi N, Németh VL, Maróti Z, Tóth-Molnár E, Oláh J, Vécsei L, Klivényi P, Kalmár T. Predominant neurological phenotype in a Hungarian family with two novel mutations in the XPA gene-case series. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. PMID 31478152 DOI: 10.1007/S10072-019-04044-6  0.254
2015 Horváth K, Aschermann Z, Ács P, Bosnyák E, Deli G, Pál E, Késmárki I, Horvath R, Takacs K, Balázs E, Komoly S, Bokor M, Rigó E, Lajtos J, Takáts A, et al. [VALIDATION OF THE HUNGARIAN UNIFIED DYSKINESIA RATING SCALE]. IdeggyóGyáSzati Szemle. 68: 183-8. PMID 26182609 DOI: 10.18071/Isz.68.0183  0.253
2015 Török N, Török R, Klivényi P, Engelhardt J, Vécsei L. Investigation of vitamin D receptor polymorphisms in amyotrophic lateral sclerosis. Acta Neurologica Scandinavica. PMID 26190642 DOI: 10.1111/Ane.12463  0.251
2014 Horváth K, Aschermann Z, Acs P, Bosnyák E, Deli G, Pál E, Janszky J, Faludi B, Késmárki I, Komoly S, Bokor M, Rigó E, Lajtos J, Klivényi P, Dibó G, et al. Is the MDS-UPDRS a Good Screening Tool for Detecting Sleep Problems and Daytime Sleepiness in Parkinson's Disease? Parkinson's Disease. 2014: 806169. PMID 25506041 DOI: 10.1155/2014/806169  0.251
2022 Salamon A, Zádori D, Szpisjak L, Klivényi P, Vécsei L. The genetic background of Parkinson's disease and novel therapeutic targets. Expert Opinion On Therapeutic Targets. 26: 827-836. PMID 36524726 DOI: 10.1080/14728222.2022.2153037  0.25
2016 Halász L, Kis D, Entz L, Tamás G, Klivényi P, Fabó D, Barzó P, Ero˝ss L. EP 77. Target identification in deep brain stimulation for Parkinson’s disease: The role of probabilistic tractography Clinical Neurophysiology. 127. DOI: 10.1016/J.Clinph.2016.05.259  0.25
2016 Szekeres M, Ivitz E, Datki Z, Kálmán J, Pákáski M, Várhelyi ZP, Klivényi P, Zadori D, Somogyvári F, Szolnoki Z, Vécsei L, Mándi Y. Relevance of defensin β-2 and α defensins (HNP1-3) in Alzheimer's disease. Psychiatry Research. 239: 342-5. PMID 27082275 DOI: 10.1016/J.Psychres.2016.03.045  0.25
2016 Szalardy L, Zadori D, Klivenyi P, Vécsei L. The Role of Cerebrospinal Fluid Biomarkers in the Evolution of Diagnostic Criteria in Alzheimer's Disease: Shortcomings in Prodromal Diagnosis. Journal of Alzheimer's Disease : Jad. PMID 27163812 DOI: 10.3233/Jad-160037  0.247
2019 Cseh EK, Veres G, Danics K, Szalárdy L, Nánási N, Klivényi P, Vécsei L, Zádori D. A tau fehérje meghatározás kiegészítő szerepe a Creutzfeldt-Jakob-betegség diagnosztikájában Ideggyogyaszati Szemle-Clinical Neuroscience. 72: 39-47. DOI: 10.18071/Isz.Https://Doi.Org/10.18071/Isz.72.0039  0.246
2020 Fakan B, Reisz Z, Zadori D, Vecsei L, Klivenyi P, Szalardy L. Predictors of localization, outcome, and etiology of spontaneous intracerebral hemorrhages: focus on cerebral amyloid angiopathy. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 32193732 DOI: 10.1007/S00702-020-02174-2  0.246
2013 Szalardy L, Zadori D, Tanczos E, Simu M, Bencsik K, Vecsei L, Klivenyi P. Increased PPAR-gamma levels in the CSF of patients with multiple sclerosis Journal of the Neurological Sciences. 333: e358. DOI: 10.1016/J.Jns.2013.07.1312  0.246
2012 Klivényi P, Nemeth D, Sefcsik T, Janacsek K, Hoffmann I, Haden GP, Londe Z, Vecsei L. Cognitive functions in ataxia with oculomotor apraxia type 2. Frontiers in Neurology. 3: 125. PMID 23015802 DOI: 10.3389/Fneur.2012.00125  0.245
2020 Holczer A, Németh VL, Vékony T, Vécsei L, Klivényi P, Must A. Non-invasive Brain Stimulation in Alzheimer's Disease and Mild Cognitive Impairment-A State-of-the-Art Review on Methodological Characteristics and Stimulation Parameters. Frontiers in Human Neuroscience. 14: 179. PMID 32523520 DOI: 10.3389/Fnhum.2020.00179  0.245
2017 Veres G, Szpisjak L, Bajtai A, Siska A, Klivényi P, Ilisz I, Földesi I, Vécsei L, Zádori D. The establishment of tocopherol reference intervals for Hungarian adult population using validated HPLC method. Biomedical Chromatography : Bmc. PMID 28182842 DOI: 10.1002/Bmc.3953  0.241
2015 Zádori D, Veres G, Szalárdy L, Klivényi P, Vécsei L. Drug-induced movement disorders. Expert Opinion On Drug Safety. 14: 877-90. PMID 25981904 DOI: 10.1517/14740338.2015.1032244  0.239
2003 Karg E, Klivenyi P, Bencsik K, Turi S, Vecsei L. Alpha-tocopherol and NADPH in the erythrocytes and plasma of multiple sclerosis patients. Effect of interferon-beta-1b treatment. European Neurology. 50: 215-9. PMID 14634265 DOI: 10.1159/000073862  0.237
2016 Szpisjak L, Obal I, Engelhardt JI, Vecsei L, Klivenyi P. A novel SETX gene mutation producing ataxia with oculomotor apraxia type 2. Acta Neurologica Belgica. PMID 26811093 DOI: 10.1007/S13760-015-0569-Y  0.236
2009 Kovacs N, Auer T, Balas I, Karadi K, Zambo K, Schwarcz A, Klivenyi P, Jokeit H, Horvath K, Nagy F, Janszky J. Neuroimaging and cognitive changes during déjà vu. Epilepsy & Behavior : E&B. 14: 190-6. PMID 18804184 DOI: 10.1016/J.Yebeh.2008.08.017  0.235
2020 Annamária Boros F, Vécsei L, Klivényi P. NEAT1 on the Field of Parkinson's Disease: Offense, Defense, or a Player on the Bench? Journal of Parkinson's Disease. PMID 33325399 DOI: 10.3233/JPD-202374  0.234
2020 Salamon A, Dézsi L, Radics B, Varga ET, Hortobágyi T, Tömösvári A, Vécsei L, Klivényi P, Rajda C. CANOMAD syndrome with respiratory failure. Ideggyogyaszati Szemle. 73: 141-144. PMID 32364342 DOI: 10.18071/Isz.73.0141  0.234
2021 Salamon A, Szpisjak L, Zádori D, Lénárt I, Maróti Z, Kalmár T, Brierley CMH, Deegan PB, Klivényi P. Atypical presentation of late-onset Sandhoff disease: a case report. Ideggyogyaszati Szemle. 74: 425-429. PMID 34856081 DOI: 10.18071/isz.74.0425  0.233
2009 Sefcsik T, Nemeth D, Janacsek K, Hoffmann I, Scialabba J, Klivenyi P, Ambrus GG, Haden G, Vecsei L. The role of the putamen in cognitive functions — A case study Learning & Perception. 1: 215-227. DOI: 10.1556/Lp.1.2009.2.4  0.232
2016 Annus Á, Bencsik K, Járdánházy T, Vécsei L, Klivényi P. Unilateral thalamic infarction causing downward gaze palsy in a patient with uncorrected tetralogy of fallot: a case report. Ideggyogyaszati Szemle. 69: 415-419. PMID 29733560 DOI: 10.18071/Isz.69.0415  0.228
2017 Szpisjak L, Nemeth VL, Szepfalusi N, Zadori D, Maroti Z, Kalmar T, Vecsei L, Klivenyi P. Neurocognitive Characterization of an SCA28 Family Caused by a Novel AFG3L2 Gene Mutation. Cerebellum (London, England). PMID 28660440 DOI: 10.1007/S12311-017-0870-9  0.228
2013 Nagy H, Takats A, Klivényi P, Kovács N. Clinical experience with continuous intestinal dopaminergic therapy: A perspective from Hungary Journal of the Neurological Sciences. 333: e101. DOI: 10.1016/J.Jns.2013.07.620  0.227
2014 Tánczos T, Zádori D, Jakab K, Hnyilicza Z, Klivényi P, Keresztes L, Engelhardt J, Németh D, Vécsei L. The role of cognitive training in the neurorehabilitation of a patient who survived a lightning strike. A case study. Neurorehabilitation. 35: 137-46. PMID 24990020 DOI: 10.3233/Nre-141106  0.227
2016 Klivenyi P, Torok R, Sumegi E, Salamon A, Vecsei L. L13 Stimulation of the PGC-1A expression in mouse brain Journal of Neurology, Neurosurgery, and Psychiatry. 87. DOI: 10.1136/Jnnp-2016-314597.268  0.224
2016 Jakó M, Surányi A, Janáky M, Klivényi P, Kaizer L, Vécsei L, Bártfai G, Németh G. Postnatal outcome and placental blood flow after plasmapheresis during pregnancy. The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 1-4. PMID 27924673 DOI: 10.1080/14767058.2016.1262344  0.224
2015 Zádor F, Lénárt N, Csibrány B, Sántha M, Molnár M, Tuka B, Samavati R, Klivényi P, Vécsei L, Marton A, Vizler C, Nagy GM, Borsodi A, Benyhe S, Páldy E. Low dosage of rimonabant leads to anxiolytic-like behavior via inhibiting expression levels and G-protein activity of kappa opioid receptors in a cannabinoid receptor independent manner. Neuropharmacology. 89: 298-307. PMID 25446673 DOI: 10.1016/J.Neuropharm.2014.10.008  0.222
2020 Biernacki T, Sandi D, Fricska-Nagy Z, Kincses ZT, Füvesi J, Laczkó R, Kokas Z, Klivényi P, Vécsei L, Bencsik K. Epidemiology of multiple sclerosis in Central Europe, update from Hungary. Brain and Behavior. e01598. PMID 32196981 DOI: 10.1002/Brb3.1598  0.219
2020 Fakan B, Reisz Z, Zadori D, Vecsei L, Klivenyi P, Szalardy L. Correction to: Predictors of localization, outcome, and etiology of spontaneous intracerebral hemorrhages: focus on cerebral amyloid angiopathy. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 32388795 DOI: 10.1007/S00702-020-02195-X  0.216
2014 Grozdics E, Berta L, Bajnok A, Veres G, Ilisz I, Klivényi P, Rigó J, Vécsei L, Tulassay T, Toldi G. B7 costimulation and intracellular indoleamine-2,3-dioxygenase (IDO) expression in peripheral blood of healthy pregnant and non-pregnant women. Bmc Pregnancy and Childbirth. 14: 306. PMID 25189405 DOI: 10.1186/1471-2393-14-306  0.213
2022 Kelemen A, Halász L, Erőss L, Rudas G, Muthuraman M, Zádori D, Laczó B, Kis D, Klivényi P, Fekete G, Bognár L, Bereczki D, Tamás G. Factors affecting postural instability after more than one-year bilateral subthalamic stimulation in Parkinson's disease: A cross-sectional study. Plos One. 17: e0264114. PMID 35196348 DOI: 10.1371/journal.pone.0264114  0.211
1995 Bencsik K, Klivényi P, Rajda C, Vécsel L. The prevalence of multiple sclerosis in regard to patients treated and nursed at the department of neurology, Albert Szent-Györoyi Medical School, Szeged, Hungary Journal of Neuroimmunology. 56: 29-29. DOI: 10.1016/0165-5728(95)98943-6  0.21
2015 Zádori D, Máté A, Róna-Vörös K, Gergev G, Zimmermann A, Nagy N, Széll M, Vécsei L, Sztriha L, Klivényi P. The clinical manifestations of two novel SPAST mutations. Clinical Neurology and Neurosurgery. 136: 82-5. PMID 26086985 DOI: 10.1016/J.Clineuro.2015.05.009  0.209
2023 Vollstedt EJ, Schaake S, Lohmann K, Padmanabhan S, Brice A, Lesage S, Tesson C, Vidailhet M, Wurster I, Hentati F, Mirelman A, Giladi N, Marder K, Waters C, Fahn S, et al. Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 36692014 DOI: 10.1002/mds.29288  0.203
2022 Török N, Maszlag-Török R, Molnár K, Szolnoki Z, Somogyvári F, Boda K, Tanaka M, Klivényi P, Vécsei L. Single Nucleotide Polymorphisms of Indoleamine 2,3-Dioxygenase 1 Influenced the Age Onset of Parkinson's Disease. Frontiers in Bioscience (Landmark Edition). 27: 265. PMID 36224022 DOI: 10.31083/j.fbl2709265  0.197
2019 Annus Á, Nagy A, Vécsei L, Klivényi P. 24-Hour Near-Infrared Spectroscopy Monitoring of Acute Ischaemic Stroke Patients Undergoing Thrombolysis or Thrombectomy: A Pilot Study. Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association. PMID 31182266 DOI: 10.1016/J.Jstrokecerebrovasdis.2019.05.026  0.196
2022 Salamon A, Zádori D, Szpisjak L, Klivényi P, Vécsei L. What is the impact of catechol-O-methyltransferase (COMT) on Parkinson's disease treatment? Expert Opinion On Pharmacotherapy. 1-6. PMID 35373688 DOI: 10.1080/14656566.2022.2060738  0.193
2015 Ottlakán A, Géczi T, Pécsy B, Borda B, Lantos J, Lázár G, Tiszlavicz L, Klivényi P, Furák J. [In Process Citation]. Magyar SebéSzet. 68: 219-24. PMID 26654355 DOI: 10.1556/1046.68.2015.6.1  0.192
2015 Jakó M, Surányi A, Janáky M, Klivényi P, Kaizer L, Bártfai G. P03.03: The pregnancy and postnatal outcome in neuromyelitis optica: case study Ultrasound in Obstetrics & Gynecology. 46: 128-129. DOI: 10.1002/Uog.15331  0.186
2021 Despotov K, Zádori D, Veres G, Jakab K, Gárdián G, Tóth E, Kincses TZ, Vécsei L, Ajtay A, Bereczki D, Klivényi P. Genetic epidemiological characteristics of a Hungarian subpopulation of patients with Huntington's disease. Bmc Neurology. 21: 79. PMID 33602179 DOI: 10.1186/s12883-021-02089-9  0.185
2021 Salamon A, Zádori D, Ujfalusi A, Szpisjak L, Lukács M, Bihari B, Szépfalusi N, Németh VL, Maróti Z, Horváth E, Balogh I, Bereczki C, Klivényi P, Kalmár T. Hereditary and non-hereditary etiologies associated with extensive brain calcification: case series. Metabolic Brain Disease. PMID 34287746 DOI: 10.1007/s11011-021-00790-9  0.185
2013 McFarland NR, Burdett T, Desjardins CA, Frosch MP, Schwarzschild MA, Nocker M, Scherfler C, Kiechl S, Willeit J, Schmidauer C, Gasperi A, Rungger G, Poewe W, Mahlknecht P, Seppi K, ... ... Klivenyi P, et al. Contents Vol. 12, 2013 Neurodegenerative Diseases. 12. DOI: 10.1159/000355887  0.183
2003 Oka H, Mochio S, Ku M, Huang C, Kuo H, Yen T, Chen C, Shih T, Chang H, Lo YL, Leoh TH, Dan YF, Tan YE, Nurjannah S, Fook-Chong S, ... ... Klivenyi P, et al. Contents Vol. 50, 2003 European Neurology. 50: 255-256. DOI: 10.1159/000075182  0.183
2001 Téllez-Zenteno JF, Remes-Troche JM, García-Ramos G, Estañol B, Garduño-Espinoza J, Angeli S, Carrera P, Sette MD, Assini A, Grandis M, Biancolini D, Ferrari M, Gandolfo C, Bencsik K, Rajda C, et al. Contents Vol. 46, 2001 European Neurology. 46: 233-235. DOI: 10.1159/000050817  0.183
2003 Oka H, Mochio S, Ku M, Huang C, Kuo H, Yen T, Chen C, Shih T, Chang H, Lo YL, Leoh TH, Dan YF, Tan YE, Nurjannah S, Fook-Chong S, ... ... Klivenyi P, et al. Subject Index Vol. 50, 2003 European Neurology. 50: 253-254. DOI: 10.1159/000075181  0.178
2001 Téllez-Zenteno JF, Remes-Troche JM, García-Ramos G, Estañol B, Garduño-Espinoza J, Angeli S, Carrera P, Sette MD, Assini A, Grandis M, Biancolini D, Ferrari M, Gandolfo C, Bencsik K, Rajda C, et al. Subject Index Vol. 46, 2001 European Neurology. 46: 231-232. DOI: 10.1159/000050816  0.178
2022 Despotov K, Klivényi P, Nagy I, Pálvölgyi A, Vécsei L, Rajda C. Rare co-occurrence of multiple sclerosis and Wilson's disease - case report. Bmc Neurology. 22: 178. PMID 35578211 DOI: 10.1186/s12883-022-02691-5  0.178
2020 Holczer A, Vékony T, Vécsei L, Klivényi P, Must A. P.401 Online theta-range transcranial alternating current stimulation results in slower conflict processing European Neuropsychopharmacology. 31. DOI: 10.1016/J.Euroneuro.2019.12.098  0.177
1994 Téllez-Zenteno JF, Remes-Troche JM, García-Ramos G, Estañol B, Garduño-Espinoza J, Angeli S, Carrera P, Sette MD, Assini A, Grandis M, Biancolini D, Ferrari M, Gandolfo C, Bencsik K, Rajda C, et al. Book Review / Announcements European Neurology. 34: 228-228. DOI: 10.1159/000050814  0.176
2021 Maszlag-Török R, Boros FA, Vécsei L, Klivényi P. Gene variants and expression changes of SIRT1 and SIRT6 in peripheral blood are associated with Parkinson's disease. Scientific Reports. 11: 10677. PMID 34021216 DOI: 10.1038/s41598-021-90059-z  0.173
2023 Szlepák T, Kossev AP, Csabán D, Illés A, Udvari S, Balicza P, Borsos B, Takáts A, Klivényi P, Molnár MJ. GBA-associated Parkinson's disease in Hungary: clinical features and genetic insights. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. PMID 38153678 DOI: 10.1007/s10072-023-07213-w  0.171
2023 Vollstedt EJ, Madoev H, Aasly A, Ahmad-Annuar A, Al-Mubarak B, Alcalay RN, Alvarez V, Amorin I, Annesi G, Arkadir D, Bardien S, Barker RA, Barkhuizen M, Basak AN, Bonifati V, ... ... Klivenyi P, et al. Establishing an online resource to facilitate global collaboration and inclusion of underrepresented populations: Experience from the MJFF Global Genetic Parkinson's Disease Project. Plos One. 18: e0292180. PMID 37788254 DOI: 10.1371/journal.pone.0292180  0.17
2022 Biernacki T, Kokas Z, Sandi D, Füvesi J, Fricska-Nagy Z, Faragó P, Kincses TZ, Klivényi P, Bencsik K, Vécsei L. Emerging Biomarkers of Multiple Sclerosis in the Blood and the CSF: A Focus on Neurofilaments and Therapeutic Considerations. International Journal of Molecular Sciences. 23. PMID 35328802 DOI: 10.3390/ijms23063383  0.161
2022 Csaban D, Illes A, Renata TB, Balicza P, Pentelenyi K, Molnar V, Gezsi A, Grosz Z, Gal A, Kovacs T, Klivenyi P, Molnar MJ. Genetic landscape of early-onset dementia in Hungary. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. PMID 35752680 DOI: 10.1007/s10072-022-06168-8  0.157
2021 Traschütz A, Reich S, Adarmes AD, Anheim M, Ashrafi MR, Baets J, Basak AN, Bertini E, Brais B, Gagnon C, Gburek-Augustat J, Hanagasi HA, Heinzmann A, Horvath R, de Jonghe P, ... ... Klivenyi P, et al. The ARCA Registry: A Collaborative Global Platform for Advancing Trial Readiness in Autosomal Recessive Cerebellar Ataxias. Frontiers in Neurology. 12: 677551. PMID 34248822 DOI: 10.3389/fneur.2021.677551  0.154
2023 Polyák H, Galla Z, Nánási N, Cseh EK, Rajda C, Veres G, Spekker E, Szabó Á, Klivényi P, Tanaka M, Vécsei L. The Tryptophan-Kynurenine Metabolic System Is Suppressed in Cuprizone-Induced Model of Demyelination Simulating Progressive Multiple Sclerosis. Biomedicines. 11. PMID 36979924 DOI: 10.3390/biomedicines11030945  0.149
2022 Sandi D, Kokas Z, Biernacki T, Bencsik K, Klivényi P, Vécsei L. Proteomics in Multiple Sclerosis: The Perspective of the Clinician. International Journal of Molecular Sciences. 23. PMID 35563559 DOI: 10.3390/ijms23095162  0.144
2014 Horvath K, Aschermann Zsuzsanna, Acs P, Bosnyák E, Deli G, Pál E, Késmárki I, Horváth Réka, Takács K, Komoly S, Bokor M, Rigó E, Lajtos J, Klivényi P, Dibó G, et al. [VALIDATION OF THE HUNGARIAN MDS-UPDRS: WHY DO WE NEED A NEW PARKINSON SCALE?]. IdeggyóGyáSzati Szemle. 67: 129-34. PMID 26118257  0.142
2024 Nagy ZF, Pál M, Engelhardt JI, Molnár MJ, Klivényi P, Széll M. Beyond C9orf72: repeat expansions and copy number variations as risk factors of amyotrophic lateral sclerosis across various populations. Bmc Medical Genomics. 17: 30. PMID 38254109 DOI: 10.1186/s12920-024-01807-9  0.141
2022 Kelemen A, Halász L, Muthuraman M, Erőss L, Barsi P, Zádori D, Laczó B, Kis D, Klivényi P, Fekete G, Bognár L, Bereczki D, Tamás G. Clinical parameters predict the effect of bilateral subthalamic stimulation on dynamic balance parameters during gait in Parkinson's disease. Frontiers in Neurology. 13: 917187. PMID 36226087 DOI: 10.3389/fneur.2022.917187  0.135
2021 Momtazmanesh S, Shobeiri P, Saghazadeh A, Teunissen CE, Burman J, Szalardy L, Klivenyi P, Bartos A, Fernandes A, Rezaei N. Neuronal and glial CSF biomarkers in multiple sclerosis: a systematic review and meta-analysis. Reviews in the Neurosciences. PMID 33594840 DOI: 10.1515/revneuro-2020-0145  0.133
2022 Füvesi J, Kincses TZ, Légrádi D, Vécsei L, Klivényi P, Bencsik K, Fricska-Nagy Z. [Follow up examination of multiple sclerosis patients treated with alemtuzumab in Multiple Sclerosis Centre, Szeged]. Ideggyogyaszati Szemle. 75: 377-384. PMID 36541148 DOI: 10.18071/isz.75.0377  0.131
2024 Nagy N, Pál M, Nagy D, Bokor BA, Zimmermann A, Gellén B, Salamon A, Sztriha L, Klivényi P, Széll M. A novel de novo truncating variant in a Hungarian patient with CTNNB1 neurodevelopmental disorder. Bmc Pediatrics. 24: 47. PMID 38225558 DOI: 10.1186/s12887-023-04509-w  0.13
2022 Veréb D, Kovács MA, Antal S, Kocsis K, Szabó N, Kincses B, Bozsik B, Faragó P, Tóth E, Király A, Klivényi P, Zádori D, Kincses ZT. Modulation of cortical resting state functional connectivity during a visuospatial attention task in Parkinson's disease. Frontiers in Neurology. 13: 927481. PMID 36016543 DOI: 10.3389/fneur.2022.927481  0.128
2023 Boros FA, Szpisjak L, Bozó R, Kelemen E, Zádori D, Salamon A, Danis J, Kalmár T, Maróti Z, Molnár MJ, Klivényi P, Széll M, Ádám É. Spinocerebellar Ataxia in a Hungarian Female Patient with a Novel Variant of Unknown Significance in the Gene. International Journal of Molecular Sciences. 24. PMID 36768938 DOI: 10.3390/ijms24032617  0.126
2024 Szabó M, Gárdián G, Szpisjak L, Salamon A, Gábor T, Klivényi P, Zádori D. The Application of Goal Attainment Scaling in Cervical Dystonia - An Exploratory Observational Pilot Study. Movement Disorders Clinical Practice. PMID 38828630 DOI: 10.1002/mdc3.14118  0.12
2024 István Antal S, Szabó N, Klucsai R, Klivényi P, Kincses ZT. Examining the prevalence of left atrial appendage thrombus in a cohort of acute stroke patients with an extended CT angiographic protocol. European Neurology. PMID 38749403 DOI: 10.1159/000539170  0.12
2021 Boczán J, Klivényi P, Kálmán B, Széll M, Karcagi V, Zádori D, Molnár JM. [Consensus statement of the Hungarian Clinical Neurogenic Society about the therapy of adult SMA patients]. Ideggyogyaszati Szemle. 74: 79-86. PMID 33938671 DOI: 10.18071/isz.74.0079  0.116
2022 Nagy ZF, Pál M, Salamon A, Kafui Esi Zodanu G, Füstös D, Klivényi P, Széll M. Re-analysis of the Hungarian amyotrophic lateral sclerosis population and evaluation of novel ALS genetic risk variants. Neurobiology of Aging. 116: 1-11. PMID 35525134 DOI: 10.1016/j.neurobiolaging.2022.04.002  0.11
2023 Nagy ZF, Sonkodi B, Pál M, Klivényi P, Széll M. Likely Pathogenic Variants of Ca1.3 and Na1.1 Encoding Genes in Amyotrophic Lateral Sclerosis Could Elucidate the Dysregulated Pain Pathways. Biomedicines. 11. PMID 36979911 DOI: 10.3390/biomedicines11030933  0.108
2021 Polyák H, Cseh EK, Bohár Z, Rajda C, Zádori D, Klivényi P, Toldi J, Vécsei L. Cuprizone markedly decreases kynurenic acid levels in the rodent brain tissue and plasma. Heliyon. 7: e06124. PMID 33553777 DOI: 10.1016/j.heliyon.2021.e06124  0.108
2021 Faragó P, Fricska-Nagy Z, Klivényi P, Tajti J. Rare complication of West Nile viral encephalitis. Ideggyogyaszati Szemle. 74: 430-432. PMID 34856080 DOI: 10.18071/isz.74.0430  0.104
2023 Szalardy L, Fakan B, Maszlag-Torok R, Ferencz E, Reisz Z, Radics BL, Csizmadia S, Szpisjak L, Annus A, Zadori D, Kovacs GG, Klivenyi P. Identifying diagnostic and prognostic factors in cerebral amyloid angiopathy-related inflammation: a systematic analysis of published and seven new cases. Neuropathology and Applied Neurobiology. e12946. PMID 38093468 DOI: 10.1111/nan.12946  0.098
2023 Salamon A, Nagy ZF, Pál M, Szabó M, Csősz Á, Szpisjak L, Gárdián G, Zádori D, Széll M, Klivényi P. Genetic Screening of a Hungarian Cohort with Focal Dystonia Identified Several Novel Putative Pathogenic Gene Variants. International Journal of Molecular Sciences. 24. PMID 37445923 DOI: 10.3390/ijms241310745  0.091
2021 Veréb D, Kovács MA, Kocsis K, Tóth E, Bozsik B, Király A, Kincses B, Faragó P, Fricska-Nagy Z, Bencsik K, Klivényi P, Kincses ZT, Szabó N. Functional Connectivity Lateralisation Shift of Resting State Networks is Linked to Visuospatial Memory and White Matter Microstructure in Relapsing-Remitting Multiple Sclerosis. Brain Topography. PMID 34807323 DOI: 10.1007/s10548-021-00881-x  0.088
2020 Babarczy K, Reisz Z, Szabo E, Rajda C, Vecsei L, Bodi I, Klivenyi P, Hortobagyi T, Szalardy L. A longitudinally extensive H3 K27M-mutant diffuse midline glioma in an elderly patient clinically mimicking central nervous system inflammation: a case report. Folia Neuropathologica. 58: 377-385. PMID 33480242 DOI: 10.5114/fn.2020.102440  0.088
2023 Adamec I, Brecl Jakob G, Rajda C, Drulović J, Radulović L, Bašić Kes V, Lazibat I, Rimac J, Cindrić I, Gržinčić T, Abičić A, Barun B, Gabelić T, Gomezelj S, Mesaroš Š, et al. Cladribine tablets in people with relapsing multiple sclerosis: A real-world multicentric study from southeast European MS centers. Journal of Neuroimmunology. 382: 578164. PMID 37536052 DOI: 10.1016/j.jneuroim.2023.578164  0.087
2022 Kokas Z, Sandi D, Fricska-Nagy Z, Füvesi J, Biernacki T, Köves Á, Fazekas F, Birkás AJ, Katona G, Kovács K, Milanovich D, Dobos E, Kapás I, Jakab G, Csépány T, et al. Do Hungarian multiple sclerosis care units fulfil international criteria? Plos One. 17: e0264328. PMID 35239686 DOI: 10.1371/journal.pone.0264328  0.086
2021 Boros FA, Maszlag-Török R, Szűcs M, Annus Á, Klivényi P, Vécsei L. Relationships of Ischemic Stroke Occurrence and Outcome with Gene Variants Encoding Enzymes of Tryptophan Metabolism. Biomedicines. 9. PMID 34680558 DOI: 10.3390/biomedicines9101441  0.083
2023 Traschütz A, Adarmes-Gomez AD, Anheim M, Baets J, Brais B, Gagnon C, Gburek-Augustat J, Doss S, Hanagasi HA, Kamm C, Klivenyi P, Klockgether T, Klopstock T, Minnerop M, Münchau A, et al. Responsiveness of the SARA and natural history in 884 recessive and early onset ataxia patients. Annals of Neurology. PMID 37243847 DOI: 10.1002/ana.26712  0.081
2021 Annus Á, Tömösi F, Rárosi F, Fehér E, Janáky T, Kecskeméti G, Toldi J, Klivényi P, Sztriha L, Vécsei L. Kynurenic acid and kynurenine aminotransferase are potential biomarkers of early neurological improvement after thrombolytic therapy: A pilot study. Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University. 30: 1225-1232. PMID 34637198 DOI: 10.17219/acem/141646  0.078
2022 Bozsik B, Tóth E, Polyák I, Kerekes F, Szabó N, Bencsik K, Klivényi P, Kincses ZT. Reproducibility of Lesion Count in Various Subregions on MRI Scans in Multiple Sclerosis. Frontiers in Neurology. 13: 843377. PMID 35620784 DOI: 10.3389/fneur.2022.843377  0.077
2023 Traschütz A, Adarmes-Gomez AD, Anheim M, Baets J, Falkenburger BH, Gburek-Augustat J, Doss S, Kamm C, Klivenyi P, Grobe-Einsler M, Klopstock T, Minnerop M, Münchau A, Pane C, Renaud M, et al. Autosomal Recessive Cerebellar Ataxias in Europe: Frequency, Onset, and Severity in 677 Patients. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 37027459 DOI: 10.1002/mds.29397  0.076
2023 Antal SI, Kincses B, Veréb D, Király A, Tóth E, Bozsik B, Faragó P, Szabó N, Kocsis K, Bencsik K, Klivényi P, Kincses ZT. Evaluation of transorbital sonography measures of optic nerve diameter in the context of global and regional brain volume in multiple sclerosis. Scientific Reports. 13: 5578. PMID 37019969 DOI: 10.1038/s41598-023-31706-5  0.07
2020 Annus Á, Juhász LÁ, Szabó E, Rárosi F, Szpisjak L, Vécsei L, Klivényi P. Connection between small vessel disease related stroke and the MTHFR C677T polymorphism in a Hungarian population. Heliyon. 6: e05305. PMID 33163671 DOI: 10.1016/j.heliyon.2020.e05305  0.068
2024 Nyári A, Kokas Z, Szamosi S, Fricska-Nagy Z, Füvesi J, Kincses ZT, Biernacki T, Vécsei L, Klivényi P, Bencsik K, Sandi D. The 7-year follow-up of the Hungarian BICAMS validation cohort implies that cognitive performance may improve in multiple sclerosis patients. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. PMID 38280085 DOI: 10.1007/s10072-024-07347-5  0.067
2020 Veréb D, Tóth E, Bozsik B, Király A, Szabó N, Kincses B, Kocsis K, Faragó P, László V, Bencsik K, Klivényi P, Kincses ZT. Altered brain network function during attention-modulated visual processing in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520958360. PMID 33016839 DOI: 10.1177/1352458520958360  0.064
2015 Zádori D, Máté A, Róna-Vörös K, Gergev G, Zimmermann A, Nagy N, Széll M, Vécsei L, Sztriha L, Klivényi P. The clinical manifestations of two novel SPAST mutations Clinical Neurology and Neurosurgery. 136: 82-85. DOI: 10.1016/j.clineuro.2015.05.009  0.062
2023 Szabó M, DO Kiem D, Gárdián G, Szpisjak L, Salamon A, Klivényi P, Zádori D. Clinical features of cervical dystonia patients classified by the COL-CAP concept and treated with ultrasound-guided botulinum neurotoxin. Ideggyogyaszati Szemle. 76: 37-45. PMID 36892297 DOI: 10.18071/isz.76.0037  0.062
2021 Szpisjak L, Szaraz G, Salamon A, Nemeth VL, Szepfalusi N, Veres G, Kincses B, Maroti Z, Kalmar T, Rydzanicz M, Ploski R, Klivenyi P, Zadori D. Eye-tracking-aided characterization of saccades and antisaccades in SYNE1 ataxia patients: a pilot study. Bmc Neuroscience. 22: 7. PMID 33526008 DOI: 10.1186/s12868-021-00612-9  0.061
2023 Antal SI, Kincses B, Veréb D, Király A, Tóth E, Bozsik B, Faragó P, Szabó N, Kocsis K, Bencsik K, Klivényi P, Kincses ZT. Author Correction: Evaluation of transorbital sonography measures of optic nerve diameter in the context of global and regional brain volume in multiple sclerosis. Scientific Reports. 13: 16876. PMID 37803092 DOI: 10.1038/s41598-023-43994-y  0.058
2021 Faragó P, Tóth E, Szabó N N, Kocsis K, Kincses B, Bozsik B, Veréb D, Biernacki TI, Király A, Sandi D, Bencsik K, Klivényi P, Vécsei L, Kincses ZT. Connection between microstructural alterations detected by diffusion MRI and cognitive dysfunction in MS: A model-free analysis approach. Multiple Sclerosis and Related Disorders. 57: 103442. PMID 34896877 DOI: 10.1016/j.msard.2021.103442  0.058
1998 Bencsik K, Rajda C, Klivenyi P, Jardanhazy T, Torok M, Vecsei L. Therapy of relapsing-remitting multiple sclerosis | A relapszus-remisszio korformaju sclerosis multiplex kezelese Lege Artis Medicinae. 8: 756-760.  0.055
2023 Csáti A, Szok D, Végh R, Jakab K, Sárvári PK, Terhes G, Pásztor G, Gaál M, Klivényi P, Tajti J. [Neurosyphilis or not - a case of a differential diagnostic challenge]. Ideggyogyaszati Szemle. 76: 356-360. PMID 37782058 DOI: 10.18071/isz.76.0356  0.054
2021 Kocsis K, Holczer A, Kazinczi C, Boross K, Horváth R, Németh LV, Klivényi P, Kincses ZT, Must A. Voxel-based asymmetry of the regional gray matter over the inferior temporal gyrus correlates with depressive symptoms in medicated patients with major depressive disorder. Psychiatry Research. Neuroimaging. 317: 111378. PMID 34479177 DOI: 10.1016/j.pscychresns.2021.111378  0.054
2021 Kocsis K, Szabó N, Tóth E, Király A, Faragó P, Kincses B, Veréb D, Bozsik B, Boross K, Katona M, Bodnár P, László NG, Vécsei L, Klivényi P, Bencsik K, et al. Two Classes of T1 Hypointense Lesions in Multiple Sclerosis With Different Clinical Relevance. Frontiers in Neurology. 12: 619135. PMID 33746876 DOI: 10.3389/fneur.2021.619135  0.048
2022 Kis O, Steklács J, Jakab K, Klivényi P. [Investigation of reading abilities of ischemic stroke patients with aphasia]. Ideggyogyaszati Szemle. 75: 397-409. PMID 36541146 DOI: 10.18071/isz.75.0397  0.048
2015 Török N, Török R, Klivényi P, Engelhardt J, Vécsei L. Investigation of vitamin D receptor polymorphisms in amyotrophic lateral sclerosis Acta Neurologica Scandinavica. DOI: 10.1111/ane.12463  0.046
2023 Holczer A, Vékony T, Klivényi P, Must A. Frontal two-electrode transcranial direct current stimulation protocols may not affect performance on a combined flanker Go/No-Go task. Scientific Reports. 13: 11901. PMID 37488206 DOI: 10.1038/s41598-023-39161-y  0.045
2023 Ostrozovicova M, Dusek P, Grofik M, Han V, Holly P, Jech R, Klivenyi P, Kovacs N, Kulcsarova K, Kurca E, Lackova A, Magocova V, Necpal J, Pinter D, Ruzicka E, et al. Central European Group on Genetics of Movement Disorders. European Journal of Neurology. PMID 38059386 DOI: 10.1111/ene.16165  0.045
2022 Hadady L, Klivényi P, Perucca E, Rampp S, Fabó D, Bereczki C, Rubboli G, Asadi-Pooya AA, Sperling MR, Beniczky S. Web-based decision support system for patient-tailored selection of antiseizure medication in adolescents and adults: An external validation study. European Journal of Neurology. 29: 382-389. PMID 34741372 DOI: 10.1111/ene.15168  0.041
2021 Nogueira RG, Qureshi MM, Abdalkader M, Martins SO, Yamagami H, Qiu Z, Mansour OY, Sathya A, Czlonkowska A, Tsivgoulis G, Aguiar de Sousa D, Demeestere J, Mikulik R, Vanacker P, Siegler JE, ... ... Klivenyi P, et al. Global Impact of COVID-19 on Stroke Care and Intravenous Thrombolysis. Neurology. PMID 33766997 DOI: 10.1212/WNL.0000000000011885  0.04
2020 Jarabin JA, Klivényi P, Tiszlavicz L, Molnár FA, Gion K, Földesi I, Kiss JG, Rovó L, Bella Z. Late simultaneous carcinomatous meningitis, temporal bone infiltrating macro-metastasis and disseminated multi-organ micro-metastases presenting with mono-symptomatic vertigo - a clinico-pathological case reporT. Ideggyogyaszati Szemle. 73: 354-360. PMID 33035412 DOI: 10.18071/isz.73.0354  0.036
2022 Annus Á, Gera FZ, Sztriha L, Klivényi P. DWI-FLAIR mismatch guided thrombolysis in patients without large-vessel occlusion: real-world data from a comprehensive stroke centre. Heliyon. 8: e12069. PMID 36506404 DOI: 10.1016/j.heliyon.2022.e12069  0.034
2021 Feher G, Hargroves D, Illes Z, Klivenyi P, Liu L, Szapary L. Editorial: Antiplatelet Agents in Stroke Prevention. Frontiers in Neurology. 12: 762060. PMID 34650516 DOI: 10.3389/fneur.2021.762060  0.03
2022 Kokas Z, Járdánházy A, Sandi D, Biernacki T, Fricska-Nagy Z, Füvesi J, Bartosik-Psujek H, Kes VB, Berger T, Berthele A, Drulovic J, Hemmer B, Horakova D, Ledinek AH, Havrdova EK, et al. Real-world operation of multiple sclerosis centres in Central-Eastern European countries covering 107 million inhabitants. Multiple Sclerosis and Related Disorders. 69: 104406. PMID 36413917 DOI: 10.1016/j.msard.2022.104406  0.026
2023 Hadady L, Sperling MR, Alcala-Zermeno JL, French JA, Dugan P, Jehi L, Fabó D, Klivényi P, Rubboli G, Beniczky S. Prediction tools and risk stratification in epilepsy surgery. Epilepsia. PMID 38060351 DOI: 10.1111/epi.17851  0.025
2021 Szpisjak L, Szaraz G, Salamon A, Nemeth VL, Szepfalusi N, Veres G, Kincses B, Maroti Z, Kalmar T, Rydzanicz M, Ploski R, Klivenyi P, Zadori D. Correction to: Eye-tracking-aided characterization of saccades and antisaccades in SYNE1 ataxia patients: a pilot study. Bmc Neuroscience. 22: 16. PMID 33691616 DOI: 10.1186/s12868-021-00621-8  0.021
2020 Fabó D, Horváth Z, Klivényi P, Kamondi A. Changes in epilepsy care during the first medical emergency period of COVID-19 pandemic in Hungary: A questionnaire survey Orvosi Hetilap. 161: 1939-1943. PMID 33190124 DOI: 10.1556/650.2020.32003  0.019
2022 Hadady L, Klivényi P, Fabó D, Beniczky S. Real-world user experience with seizure detection wearable devices in the home environment. Epilepsia. PMID 35195898 DOI: 10.1111/epi.17189  0.01
Hide low-probability matches.